A double-blind controlled clinical trial of carnidazole and tinidazole in the treatment of vaginal trichomoniasis.
P Chaudhuri, A C Drogendijk
Index: Eur. J. Obstet. Gynecol. Reprod. Biol. 10(5) , 325-8, (1980)
Full Text: HTML
Abstract
A double-blind controlled clinical trial of the new, not yet commercially available drug, carnidazole and tinidazole, was carried out in 77 women with a proven vaginal trichomoniasis. 39 patients and their sexual partners received a single dose of 2 g of carnidazole and the other 38 couples were treated in the same manner with tinidazole. The cure rate was 100% and 95% respectively. The side-effects were higher in the carnidazole group, although they were mild and well-tolerated by the patients and their partners. The history of the disease and its treatment are also briefly reviewed.
Related Compounds
Related Articles:
2015-04-15
[J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 988 , 187-94, (2015)]
1992-12-01
[J. Vet. Pharmacol. Ther. 15(4) , 409-15, (1992)]
1988-10-01
[Biomed. Environ. Mass Spectrom. 16(1-12) , 121-9, (1988)]
1979-10-01
[Rev. Med. Liege. 34(19) , 811-5, (1979)]
2006-10-01
[J. Pharm. Sci. 95(10) , 2123-36, (2006)]